GlassScriptPhysician profile
Mark Dwayne Chaney
NPI 1467055632
$1,459.05
in general payments reported to CMS, 2019-2025
17 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $308 · 2023: $310 · 2024: $412 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $684.39 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $194.47 | 2022-2025 | Repatha, Tepezza, Repatha |
| Horizon Therapeutics Plc | $147.13 | 2022-2023 | Tepezza |
| Medtronic, INC. | $94.45 | 2024-2025 | Minimed 780g |
| Lilly USA, LLC | $76.54 | 2022-2024 | Mounjaro, Humulin |
| Neurocrine Biosciences, INC. | $34.07 | 2025 | |
| Genzyme Corporation | $28.56 | 2025 | |
| Beta Bionics, INC. | $24.06 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Insulet Corporation | $23.69 | 2023 | Omnipod |
| Sanofi-Aventis U.S. LLC | $23.53 | 2023 | |
| Tandem Diabetes Care, INC. | $23.00 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Dexcom, INC. | $22.29 | 2024 | Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $19.69 | 2025 | Twiist |
| Novartis Pharmaceuticals Corporation | $16.81 | 2025 | |
| Acella Pharmaceuticals, LLC | $16.68 | 2025 | NP Thyroid 60 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.06 | 2022 | |
| Blueprint Medicines Corporation | $14.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Chaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.